Cargando…
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
Hyperammonemic encephalopathy is a rare but potentially dangerous complication of the antiepileptic drug (AED) sodium valproate (VPA). We report a retrospective study of 25 pediatric patients, (15 females [60%]; age: 7.6 ± 4.9 years), with different underlying disorders, who suffered from hyperammon...
Autores principales: | Palomino Pérez, Laura María, Martín‐Rivada, Álvaro, Cañedo Villaroya, Elvira, García‐Peñas, Juan José, Cuervas‐Mons Vendrell, Margarita, Pedrón‐Giner, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463051/ https://www.ncbi.nlm.nih.gov/pubmed/32905024 http://dx.doi.org/10.1002/jmd2.12131 |
Ejemplares similares
-
Two Siblings With Valproate-Related Hyperammonemia and Novel Mutations in Glutamine Synthetase (GLUL) Treated With Carglumic Acid
por: Bennett, Jennifer, et al.
Publicado: (2020) -
Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?
por: Levrat, Virginie, et al.
Publicado: (2008) -
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
por: Daniotti, Marta, et al.
Publicado: (2011) -
Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose carglumic acid
por: Kasapkara, Çiğdem Seher, et al.
Publicado: (2013) -
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
por: Häberle, Johannes
Publicado: (2011)